MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0022552

Медицинская библиотека · PloS one · 2011

Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients.

Gullo Damiano, Latina Adele, Frasca Francesco, Le Moli Rosario, Pellegriti Gabriella, Vigneri Riccardo

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

CONTEXT: Levothyroxine monotherapy is the treatment of choice for hypothyroid patients because peripheral T4 to T3 conversion is believed to account for the overall tissue requirement for thyroid hormones. However, there are indirect evidences that this may not be the case in all patients.

OBJECTIVE

To evaluate in a large series of athyreotic patients whether levothyroxine monotherapy can normalize serum thyroid hormones and thyroid-pituitary feedback.

DESIGN

Retrospective study.

SETTING

Academic hospital.

PATIENTS: 1,811 athyreotic patients with normal TSH levels under levothyroxine monotherapy and 3,875 euthyroid controls.

MEASUREMENTS: TSH, FT4 and FT3 concentrations by immunoassays.

RESULTS

FT4 levels were significantly higher and FT3 levels were significantly lower (p<0.001 in both cases) in levothyroxine-treated athyreotic patients than in matched euthyroid controls. Among the levothyroxine-treated patients 15.2% had lower serum FT3 and 7.2% had higher serum FT4 compared to euthyroid controls. A wide range of FT3/FT4 ratios indicated a major heterogeneity in the peripheral T3 production capacity in different individuals. The correlation between thyroid hormones and serum TSH levels indicated an abnormal feedback mechanism in levothyroxine-treated patients.

CONCLUSIONS

Athyreotic patients have a highly heterogeneous T3 production capacity from orally administered levothyroxine. More than 20% of these patients, despite normal TSH levels, do not maintain FT3 or FT4 values in the reference range, reflecting the inadequacy of peripheral deiodination to compensate for the absent T3 secretion. The long-term effects of chronic tissue exposure to abnormal T3/T4 ratio are unknown but a sensitive marker of target organ response to thyroid hormones (serum TSH) suggests that this condition causes an abnormal pituitary response. A more physiological treatment than levothyroxine monotherapy may be required in some hypothyroid patients.

Для цитирования: Gullo Damiano, Latina Adele, Frasca Francesco, Le Moli Rosario, Pellegriti Gabriella, Vigneri Riccardo. Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients.. PloS one. 2011. DOI: 10.1371/journal.pone.0022552.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.